Jirapas Sripetchwandee

Jirapas Sripetchwandee

Auto-generated profile, based on publicly available information

Jirapas Sripetchwandee

Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine Chiang Mai University Suthep Thailand

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJirapas Sripetchwandee
Jirapas Sripetchwandee
NPNoppamas Pipatpiboon
Noppamas Pipatpiboon
NCNipon Chattipakorn
Nipon Chattipakorn
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn
Excessive iron accumulation leads to iron toxicity in the brain; however the underlying mechanism is unclear. We investigated the effects of iron overload induced by high iron-diet consumption on brain mitochondrial function, brain synaptic plasticity and learning and memory. Iron chelator (deferiprone) and antioxidant (n-acetyl cysteine) effects on iron-overload brains were also studied. Male Wistar rats were fed either normal diet or high iron-diet consumption for 12 weeks, after which rats in each diet group were treated with vehicle or deferiprone (50 mg/kg) or n-acetyl cysteine (100 mg/kg) or both for another 4 weeks. High iron-diet consumption caused brain iron accumulation, brain mitochondrial dysfunction, impaired brain synaptic plasticity and cognition, blood-brain-barrier breakdown, and brain apoptosis. Although both iron chelator and antioxidant attenuated these deleterious effects, combined therapy provided more robust results. In conclusion, this is the first study demonstrating that combined iron chelator and anti-oxidant therapy completely restored brain function impaired by iron overload.

1 June 2015 in Hormones and Behavior
Verified
Journal Article
Closed access
WPWasana Pratchayasakul
Wasana Pratchayasakul
PSPiangkwan Sa-Nguanmoo
Piangkwan Sa-Nguanmoo
SSSivaporn Sivasinprasasn
Sivaporn Sivasinprasasn
HPHiranya Pintana
Hiranya Pintana
RTRungroj Tawinvisan
Rungroj Tawinvisan
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn

5 October 2013 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
JSJ. Sripetchwandee
J. Sripetchwandee
SKS. B. KenKnight
S. B. KenKnight
JSJ. Sanit
J. Sanit
SCS. Chattipakorn
S. Chattipakorn
NCNipon Chattipakorn
Nipon Chattipakorn

1 September 2016 in Neuroscience
Verified
Journal Article
Closed access
JSJirapas Sripetchwandee
Jirapas Sripetchwandee
SWSuwakon Wongjaikam
Suwakon Wongjaikam
WKWarunsorn Krintratun
Warunsorn Krintratun
NCNipon Chattipakorn
Nipon Chattipakorn
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn

18 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SWSuwakon Wongjaikam
Suwakon Wongjaikam
SKSirinart Kumfu
Sirinart Kumfu
JKJuthamas Khamseekaew
Juthamas Khamseekaew
JSJirapas Sripetchwandee
Jirapas Sripetchwandee
SSSomdet Srichairatanakool
Somdet Srichairatanakool
NCNipon Chattipakorn
Nipon Chattipakorn
Iron chelators are used to treat iron overload cardiomyopathy patients. However, a direct comparison of the benefits of three common iron chelators (deferoxamine (DFO), deferiprone (DFP) and deferasirox (DFX)) or an antioxidant (N-acetyl cysteine (NAC)) with a combined DFP and NAC treatments on left ventricular (LV) function with iron overload has not been investigated. Male Wistar rats were fed with either a normal diet or a high iron diet (HFe group) for 4 months. After 2 months, the HFe-fed rats were divided into 6 groups to receive either: a vehicle, DFO (25 mg/kg/day), DFP (75 mg/kg/day), DFX (20 mg/kg/day), NAC (100 mg/kg/day) or the combined DFP and NAC for 2 months. Our results demonstrated that HFe rats had increased plasma non-transferrin bound iron (NTBI), malondialdehyde (MDA), cardiac iron and MDA levels and cardiac mitochondrial dysfunction, leading to LV dysfunction. Although DFO, DFP, DFX or NAC improved these parameters, leading to improved LV function, the combined DFP and NAC therapy caused greater improvement, leading to more extensively improved LV function. The combined DFP and NAC treatment had greater efficacy than monotherapy in cardioprotection through the reduction of cardiac iron deposition and improved cardiac mitochondrial function in iron-overloaded rats.

1 March 2013 in Life Sciences
Verified
Journal Article
Closed access
JSJirapas Sripetchwandee
Jirapas Sripetchwandee
JSJantira Sanit
Jantira Sanit
NCNipon Chattipakorn
Nipon Chattipakorn
SCSiriporn C. Chattipakorn
Siriporn C. Chattipakorn